|
Volumn 35, Issue SUPPL. 1, 2007, Pages
|
Concomitant effects of a rapid and short acting insulin secretagogue mitiglinide in type 2 diabetes patients with inadequate control of blood glucose with voglibose monotherapy - Phase II/III double blind comparative study
a b c d d |
Author keywords
Combination therapy; HbA1C; Mitiglinide; Postprandial blood glucose; Voglibose
|
Indexed keywords
DNA FORMAMIDOPYRIMIDINE GLYCOSYLASE;
GLUCOSE;
HEMOGLOBIN A1C;
INSULIN;
MITIGLINIDE;
SHORT ACTING DRUG;
VOGLIBOSE;
ANALYSIS OF VARIANCE;
ARTICLE;
BLOOD GLUCOSE MONITORING;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIET THERAPY;
DISEASE SEVERITY;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
DRUG EFFICACY;
DRUG SAFETY;
HUMAN;
HYPOGLYCEMIA;
INCIDENCE;
LABORATORY TEST;
MONOTHERAPY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
TREATMENT OUTCOME;
VITAL SIGN;
|
EID: 34250797429
PISSN: 03863603
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (4)
|
References (5)
|